Pnc Financial Services Group, Inc. Recursion Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 9,820 shares of RXRX stock, worth $73,551. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,820
Previous 3,062
220.71%
Holding current value
$73,551
Previous $20,000
230.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RXRX
# of Institutions
303Shares Held
242MCall Options Held
1.35MPut Options Held
2.32M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$242 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$186 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$182 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$130 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$115 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.35B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...